Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 28.
doi: 10.1007/s10926-024-10257-0. Online ahead of print.

Work Participation of Hematological Cancer Survivors After Hematopoietic Cell Transplantation: A Scoping Review

Karine Bilodeau  1   2   3   4 , Billy Vinette  5   6   7 , Charlotte Gélinas-Gagné  6 , Pegah Torabi  6 , Benedicta Hartono  5 , Marie Désilets  8 , Imran Ahmad  8 , Bertrand Porro  9   10
Affiliations
Review

Work Participation of Hematological Cancer Survivors After Hematopoietic Cell Transplantation: A Scoping Review

Karine Bilodeau et al. J Occup Rehabil. .

Abstract

Purpose: Hematopoietic cell transplantation (HCT) is a common treatment for people diagnosed with hematological cancers. However, it can cause side effects that may affect work participation. This scoping review aims to provide an overview of the factors that influence the work participation of hematological cancer survivors who have undergone HCT.

Methods: We conducted a scoping review following the Joanna Briggs Institute guidelines and developed our search strategy in collaboration with a scientific librarian and searched nine databases (CINAHL, MEDLINE, EMBASE, Cochrane, PubMed, PsycINFO, Web of Science, Scopus, ProQuest Dissertations, & Theses Global) for primary studies in French or English until February 2024. Two reviewers extracted the data and analyzed it thematically. We synthesized and presented the findings using a narrative description approach.

Results: We identified 940 publications, of which 36 met the eligibility criteria. Our findings underscore the significance of considering individuals over 50, those undergoing allogeneic HCT, women, and those with lower incomes. We noted disparities in evaluating or describing work participation.

Conclusion: It is crucial for researchers and healthcare professionals in hematological care to be aware of the intersecting factors that influence work participation. There are still significant gaps in how workplace dynamics, legislation, and healthcare systems affect the return to work process.

Keywords: Cancer; Cell; Review; Transplantation; Work.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

References

    1. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75. https://doi.org/10.1016/s0140-6736(17)33326-3 . - DOI - PubMed - PMC
    1. Balassa K, Danby R, Rocha V. Haematopoietic stem cell transplants: principles and indications. Br J Hosp Med (Lond). 2019;80(1):33–9. https://doi.org/10.12968/hmed.2019.80.1.33 . - DOI - PubMed
    1. Bazarbachi A, Labopin M, Battipaglia G, Djabali A, Passweg J, Socié G, et al. Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party. Haematologica. 2019;104(9):e398–401. https://doi.org/10.3324/haematol.2018.211615 . - DOI - PubMed - PMC
    1. Allart-Vorelli P, Porro B, Baguet F, Michel A, Cousson-Gélie F. Haematological cancer and quality of life: a systematic literature review. Blood Cancer J. 2015;5(4):e305. https://doi.org/10.1038/bcj.2015.29 . - DOI - PubMed - PMC
    1. Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G, et al. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 2023;13(1):82. https://doi.org/10.1038/s41408-023-00853-3 . - DOI - PubMed - PMC

LinkOut - more resources